ClinicalTrials.gg
RecruitingNCT07468019Updated Mar 12, 2026

Organization's Unique Protocol ID

An interventional study of 3-D printed overdenture and Conventional overdenture in Ectodermal Dysplasia, sponsored by Cairo University. Recruiting at 1 site in Egypt. Open to participants aged 10 Years to 35 Years. Per ClinicalTrials.gov, last updated 2026-03-12.

Sponsored by Cairo University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Feb 2026; still recruiting 9 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
11
Allocation
Non-randomized
Ages
10 Years to 35 Years
Sex
All
01

Study summary

Ectodermal dysplasia is a rare inherited condition that affects structures derived from the ectoderm, including teeth, skin, hair, and sweat glands. Dental findings are often severe and include missing or malformed teeth and poorly developed jaw ridges. These abnormalities can significantly affect chewing, speech, facial appearance, and quality of life, especially in children and young adults. Removable dentures, particularly overdentures when some teeth are present, are commonly used to restore function and appearance in these patients because they are conservative and cost-effective. However, conventional acrylic dentures may show dimensional changes during processing, which can lead to poor denture fit, reduced retention, and lower patient satisfaction. Three-dimensional (3-D) printed dentures are a newer digital fabrication method that may reduce material shrinkage and improve denture adaptation. Despite these potential advantages, clinical evidence comparing 3-D printed and conventional overdentures in patients with ectodermal dysplasia remains limited, highlighting the need for well-designed clinical studies.

The purpose of this study is to compare patient satisfaction and denture base adaptation between 3-D printed maxillary overdentures and conventional acrylic maxillary overdentures in patients with ectodermal dysplasia.

Read the detailed description

Ectodermal dysplasia patients suffer from partial anodontia, the reduced number of teeth leads to decreased ridge development and reduced surface area of denture which negatively affects the denture adaptation. Conventionally constructed dentures are well accepted but have high polymerization shrinkage which affects denture adaptation. 3D printed dentures offer less polymerization shrinkage when compared to conventional dentures. Clinical studies that investigated digitally manufactured, especially 3D printed, dentures in ectodermal dysplasia patients and their impact on patient satisfaction and denture adaptation are very scarce in dental literature.

02

Conditions studied

  • Ectodermal Dysplasia

Browse trials for

03

In context

Ectodermal Dysplasia

10 studies on the registry are indexed under Ectodermal Dysplasia; 6 are open to participants now.

Browse Ectodermal Dysplasia studies →

Lead sponsor

Cairo University is the lead sponsor of 4,941 studies on the registry; 1,458 are open to participants now.

Of its 37 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
10 Years to 35 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age must range from 10-35 years.
  • Must have a few remaining teeth in the maxilla.
  • Must will to attend all follow-ups.

Exclusion criteria

Exclusion Criteria:

  • Extreme anatomical limitations such as a large torus that requires surgical excision.
  • Allergy to dentures made of resins.
  • Pathological changes of residual ridges as recurrent or persistent ulcers, osteomyelitis and infections.

    4. Patients with medical or psychological conditions as physical disability or mental retardation that hinder cooperation in the follow up visits and answering the questionnaires.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Crossover assignment
Masking
Single (Participant)
Enrollment
11 participants (estimated)

Study arms

  • Experimental
    Digital 3-D printed overdentures

    Device: 3-D printed overdenture

  • Active comparator
    conventional acrylic overdenture

    Device: Conventional overdenture

Interventions

  • Device3-D printed overdenture

    Overdenture is constructed using 3 -D printing technology not conventional processing of acrylic resin

  • DeviceConventional overdenture

    overdentures will be constructed using Conventional acrylic processing method

06

What researchers measure

Primary outcomes

  1. Patient satisfaction

    Patient satisfaction will be measured using patient satisfaction questionnaire in ordinal scale. It uses a 5- point Likert scale to give a removable denture satisfaction index.

    Time frame: after 1 week and after 3 months after delivery of each denture

Secondary outcomes

  1. Denture adaptation

    Denture adaptation will be measured using surface matching software in deviation values. Unit is µm.

    Time frame: on delivery day and after 3 months of each denture delivery

07

Study locations

1 of 1 sites recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 12, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07468019
Lead sponsor
Cairo University
Responsible party
Yasmine Hisham Abd El rahman Mohsen (Principal investigator, Cairo University) — Principal investigator
First posted
Mar 12, 2026
Start date
Feb 1, 2026
Primary completion
Dec 2026 (estimated)
Completion
Dec 2026 (estimated)
Last update
Mar 12, 2026

Study contacts

Yasmine Hisham Mohsen
Contact
yasmine.hisham@dentistry.cu.edu.eg
+201007771412

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion